A realist evaluation of patients’ decisions to deprescribe in the EMPOWER trial
Open accessThe DOI matches its Crossref record; 16 of the 16 references it cites were found in a registry or an index.
Abstract
Background and objectives: Successful mechanisms for engaging patients in the deprescribing process remain unknown but may include: (1) triggering motivation to deprescribe by increasing patients’ knowledge and concern about medications; (2) building capacity to taper by augmenting self-efficacy and (3) creating opportunities to discuss and receive support for deprescribing from a healthcare provider. We tested these mechanisms during theEliminating Medications through Patient Ownership of End Results (EMPOWER) () trial and investigated the contexts that led to positive and negative deprescribing outcomes. Design: A realist evaluation using a sequential mixed methods approach, conducted alongside the EMPOWER randomised clinical trial. Setting: Community, Quebec, Canada. Participants: 261 older chronic benzodiazepine consumers, who received the EMPOWER intervention and had complete 6-month follow-up data. Intervention: Mailed deprescribing brochure on benzodiazepines. Measurements: Motivation (intent to discuss deprescribing; change in knowledge test score; change in beliefs about the risk–benefits of benzodiazepines, measured with the Beliefs about Medicines Questionnaire), capacity (self-efficacy for tapering) and opportunity (support from a physician or pharmacist). Results: The intervention triggered the motivation to deprescribe among 167 (n=64%) participants (mean age 74.6 years±6.3, 72% women), demonstrated by improved knowledge (risk difference, 58.50% (95% CI 46.98% to 67.44%)) and increased concern about taking benzodiazepines (risk difference, 67.67% (95% CI 57.36% to 74.91%)). Those who attempted to taper exhibited increased self-efficacy (risk difference, 56.90% (95% CI 45.41% to 65.77%)). Contexts where the deprescribing mechanisms failed included lack of support from a healthcare provider, a focus on short-term quality of life, intolerance to withdrawal symptoms and perceived poor health. Conclusion: Deprescribing mechanisms that target patient motivation and capacity to deprescribe yield successful outcomes in contexts where healthcare providers are supportive, and patients do not have internal competing desires to remain on drug therapy. Trial registration number: ClinicalTrials.gov: NCT01148186.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Using thematic analysis in psychology
Braun, V., & Clarke, V. (2006) · Qualitative Research in Psychology · doi:10.1191/1478088706qp063oa · Cited by 194,414
Michie, S., van Stralen, M. M., & West, R. (2011) · Implementation Science · doi:10.1186/1748-5908-6-42 · Cited by 13,697
Self-perception: An alternative interpretation of cognitive dissonance phenomena.
Bem, D. J. (1967) · Psychological Review · doi:10.1037/h0024835 · Cited by 2,959
By the American Geriatrics Society 2015 Beers Criteria Update Expert Panel (2015) · Journal of the American Geriatrics Society · doi:10.1111/jgs.13702 · Cited by 2,609
Ellis, P. D. (2010) · doi:10.1017/cbo9780511761676 · Cited by 2,461
Three techniques for integrating data in mixed methods studies
O'Cathain, A., Murphy, E., & Nicholl, J. (2010) · BMJ · doi:10.1136/bmj.c4587 · Cited by 1,584 · cited 1×
“The convergence matrix served to inform which contexts favourably or unfavourably influenced a patient’s decision to deprescribe based on agreement, partial agreement or dissonance between the quantitative and qualitative data.(41) 42 Differences were adjudicated via discussion and consensus.”
BackgroundThe Science of Evaluation: A Realist Manifesto
Pawson, R. (2013) · doi:10.4135/9781473913820 · Cited by 1,271
What’s in a mechanism? Development of a key concept in realist evaluation
Dalkin, S. M., Greenhalgh, J., Jones, D., Cunningham, B., & Lhussier, M. (2015) · Implementation Science · doi:10.1186/s13012-015-0237-x · Cited by 896
RAMESES II reporting standards for realist evaluations
Wong, G., Westhorp, G., Manzano, A., Greenhalgh, J., Jagosh, J., & Greenhalgh, T. (2016) · BMC Medicine · doi:10.1186/s12916-016-0643-1 · Cited by 880 · cited 2×
“This report follows online supplementary material 2 RAMESES II guidelines for realist evaluation.(16) The approach was chosen to inform the implementation of future deprescribing initiatives by examining the possible causes and contextual factors associated with change.”
BackgroundMethodTime for a change: putting the transtheoretical (stages of change) model to rest
WEST, R. (2005) · Addiction · doi:10.1111/j.1360-0443.2005.01139.x · Cited by 700
Tannenbaum, C., Martin, P., Tamblyn, R., Benedetti, A., & Ahmed, S. (2014) · JAMA Internal Medicine · doi:10.1001/jamainternmed.2014.949 · Cited by 665 · cited 2×
“Study design A realist evaluation was conducted alongside the EMPOWER randomised controlled trial.(12) This report follows online supplementary material 2 RAMESES II guidelines for realist evaluation.”
BackgroundMethodSelf-citationPatient Barriers to and Enablers of Deprescribing: a Systematic Review
Reeve, E., To, J., Hendrix, I., Shakib, S., Roberts, M. S., & Wiese, M. D. (2013) · Drugs & Aging · doi:10.1007/s40266-013-0106-8 · Cited by 536 · cited 1×
“26 Not understanding why medications should be discontinued is a patient barrier to deprescribing.(4) 27 As most patients are uninformed of the potential risks associated with the use of benzodiazepines, we hypothesised a linear behaviour change process whereby providing patients with an interactive educational brochu…”
BackgroundAllain, H., Bentu??-Ferrer, D., Polard, E., Akwa, Y., & Patat, A. (2005) · Drugs & Aging · doi:10.2165/00002512-200522090-00004 · Cited by 214
Declercq, T., Petrovic, M., Azermai, M., Vander Stichele, R., De Sutter, A. I., van Driel, M. L., & Christiaens, T. (2013) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd007726.pub2 · Cited by 206
Deprescribing benzodiazepines and Z-drugs in community-dwelling adults: a scoping review
Pollmann, A. S., Murphy, A. L., Bergman, J. C., & Gardner, D. M. (2015) · BMC Pharmacology and Toxicology · doi:10.1186/s40360-015-0019-8 · Cited by 114
Cook, J. M., Biyanova, T., Masci, C., & Coyne, J. C. (2007) · Journal of General Internal Medicine · doi:10.1007/s11606-007-0205-5 · Cited by 107
Cited by
Martin, P., Tamblyn, R., Benedetti, A., Ahmed, S., & Tannenbaum, C. (2018) · JAMA · doi:10.1001/jama.2018.16131 · Cited by 401
Self-citationDeMartini, J., Patel, G., & Fancher, T. L. (2019) · Annals of Internal Medicine · doi:10.7326/aitc201904020 · Cited by 226
Ng, B. J., Le Couteur, D. G., & Hilmer, S. N. (2018) · Drugs & Aging · doi:10.1007/s40266-018-0544-4 · Cited by 118
“On a theoretical basis [97], it also increases patient’s perceived self-efficacy for tapering (capacity) and motivates and provides opportunity to discuss cessation with a health professional [97, 98].”
BackgroundMethods in realist evaluation: A mapping review
Renmans, D., & Castellano Pleguezuelo, V. (2023) · Evaluation and Program Planning · doi:10.1016/j.evalprogplan.2022.102209 · Cited by 68
Evrard, P., Pétein, C., Beuscart, J.-B., & Spinewine, A. (2022) · Implementation Science · doi:10.1186/s13012-022-01206-7 · Cited by 62
Metadata
- Authors
- Martin, P., & Tannenbaum, C.
- Venue
- BMJ Open
- Publisher
- BMJ
- Published
- 2017-04
- Volume
- 7
- Issue
- 4
- Pages
- e015959
- ISSN
- 2044-6055 (ISSN-L)
- OpenAlex
- W2610613993
- Cited by
- 110
- References
- 16
- FWCI
- 4.44
- Type
- journal article
- Language
- en
- Open access
- gold
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.